Understanding the focused CD4 T cell response to antigen and pathogenic organisms

Immunologic Research

Volumn 45, Issue 2-3, 2009, Pages 123-143

  Weaver, Jason M ^a   Sant, Andrea J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antigen presentation processing; Antigens peptides; Immunodominance; Influenza virus vaccine design; MHC

Indexed keywords

ANTIGEN; EPITOPE; HEMAGGLUTININ; INFLUENZA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NONSTRUCTURAL PROTEIN 1; NUCLEOPROTEIN; SIALIDASE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BIOCHEMISTRY; CD4+ T LYMPHOCYTE; DRUG DESIGN; HUMAN; IMMUNE RESPONSE; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; VIRION;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNODOMINANT EPITOPES; PEPTIDES; VACCINES;

EID: 72449206256     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-009-8095-8     Document Type: Review

References (154)

1. EE Sercarz PV Lehmann A Ametani G Benichou A Miller K Moudgil 1993 Dominance and crypticity of T cell antigenic determinants Annu Rev Immunol 11 729 766 7682817
2. H Deng L Fosdick E Sercarz 1993 The involvement of antigen processing in determinant selection by class II MHC and its relationship to immunodominance APMIS 101 655 662 8240783
3. AJ Sant FA Chaves SA Jenks KA Richards P Menges JM Weaver CA Lazarski 2005 The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes Immunol Rev 207 261 278 16181342
4. PJ Fairchild 1999 Reversal of immunodominance among autoantigenic T-cell epitopes Autoimmunity 30 209 221 10524497
5. JS Blum C Ma S Kovats 1997 Antigen-presenting cells and the selection of immunodominant epitopes Crit Rev Immunol 17 411 417 9419428
6. JW Yewdell M Del Val 2004 Immunodominance in TCD8+ responses to viruses: cell biology, cellular immunology, and mathematical models Immunity 21 149 153 15308096
7. W Chen J McCluskey 2006 Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell-based cancer vaccines Adv Cancer Res 95 203 247 16860659
8. JW Yewdell 2006 Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses Immunity 25 533 543 17046682
9. KM Nikcevich D Kopielski A Finnegan 1994 Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo J Immunol 153 1015 1026 7517970
10. WP Thayer JR Kraft SM Tompkins JC Moore PE Jensen 1999 Assessment of the role of determinant selection in genetic control of the immune response to insulin in H-2b mice J Immunol 163 2549 2554 10452992
11. C Ma PE Whiteley PM Cameron DC Freed A Pressey SL Chen B Garni-Wagner C Fang DM Zaller LS Wicker JS Blum 1999 Role of APC in the selection of immunodominant T cell epitopes J Immunol 163 6413 6423 10586031
12. KD Moudgil EE Sercarz IS Grewal 1998 Modulation of the immunogenicity of antigenic determinants by their flanking residues Immunol Today 19 217 220 9613039
13. L Gapin JP Cabaniols R Cibotti DM Ojcius P Kourilsky JM Kanellopoulos 1997 Determinant selection for T-cell tolerance in HEL-transgenic mice: dissociation between immunogenicity and tolerogenicity Cell Immunol 177 77 85 9140098
14. JW Yewdell JR Bennink 1999 Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses Annu Rev Immunol 17 51 88 10358753
15. SA Safley PE Jensen PA Reay HK Ziegler 1995 Mechanisms of T cell epitope immunodominance analyzed in murine listeriosis J Immunol 155 4355 4366 7594595
16. KD Moudgil H Deng NK Nanda IS Grewal A Ametani EE Sercarz 1996 Antigen processing and T cell repertoires as crucial aleatory features in induction of autoimmunity J Autoimmun 9 227 234 8738967
17. L Adorini S Muller F Cardinaux PV Lehmann F Falcioni ZA Nagy 1988 In vivo competition between self peptides and foreign antigens in T-cell activation Nature 334 623 625 3261393
18. Z Liu KP Williams YH Chang JA Smith 1993 Immunodominance: a single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants J Immunol 151 1852 1858 7688387
19. L Vidard KL Rock B Benacerraf 1991 The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors J Immunol 147 1786 1791 1890304
20. SC Schneider J Ohmen L Fosdick B Gladstone J Guo A Ametani EE Sercarz H Deng 2000 Cutting Edge: introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display J Immunol 165 20 23 10861030
21. SJ Melton SJ Landry 2008 Three dimensional structure directs T-cell epitope dominance associated with allergy Clin Mol Allergy 6 9 18793409
22. D Mirano-Bascos M Tary-Lehmann SJ Landry 2008 Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120 Eur J Immunol 38 1231 1237 18398933
23. S Carmicle NK Steede SJ Landry 2007 Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes Mol Immunol 44 1159 1168 16893568
24. G Dai S Carmicle NK Steede SJ Landry 2002 Structural basis for helper T-cell and antibody epitope immunodominance in bacteriophage T4 Hsp10. Role of disordered loops J Biol Chem 277 161 168 11602571
25. UT Phan B Arunachalam P Cresswell 2000 Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action J Biol Chem 275 25907 25914 10852914
26. SJ Landry 2000 Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120 J Theor Biol 203 189 201 10716904
27. NK Nanda AJ Sant 2000 DM determines the cryptic and immunodominant fate of T cell epitopes J Exp Med 192 781 788 10993909
28. AJ Sant C Beeson B McFarland J Cao S Ceman PW Bryant S Wu 1999 Individual hydrogen bonds play a critical role in MHC class II: peptide interactions: implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange Immunol Rev 172 239 253 10631950
29. P Brocke N Garbi F Momburg GJ Hammerling 2002 HLA-DM, HLA-DO and tapasin: functional similarities and differences Curr Opin Immunol 14 22 29 11790529
30. PE Jensen DA Weber WP Thayer X Chen CT Dao 1999 HLA-DM and the MHC class II antigen presentation pathway Immunol Res 20 195 205 10741860
31. H Kropshofer GJ Hammerling AB Vogt 1997 How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol Today 18 77 82 9057358 (Pubitemid 27107101)
32. R Busch CH Rinderknecht S Roh AW Lee JJ Harding T Burster TM Hornell ED Mellins 2005 Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression Immunol Rev 207 242 260 16181341
33. S Sadegh-Nasseri M Chen K Narayan M Bouvier 2008 The convergent roles of tapasin and HLA-DM in antigen presentation Trends Immunol 29 141 147 18261958
34. L Lightstone R Hargreaves G Bobek M Peterson G Aichinger G Lombardi R Lechler 1997 In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM Proc Natl Acad Sci USA 94 5772 5777 9159149
35. SM van Ham U Gruneberg G Malcherek I Broker A Melms J Trowsdale 1996 Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs J Exp Med 184 2019 2024 8920889
36. S Drover S Kovats S Masewicz JS Blum GT Nepom 1998 Modulation of peptide-dependent allospecific epitopes on HLA-DR4 molecules by HLA-DM Hum Immunol 59 77 86 9536430
37. JF Katz C Stebbins E Appella AJ Sant 1996 Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules J Exp Med 184 1747 1753 8920863
38. H Kropshofer AB Vogt G Moldenhauer J Hammer JS Blum GJ Hammerling 1996 Editing of the HLA-DR-peptide repertoire by HLA-DM EMBO J 15 6144 6154 8947036
39. AB Vogt H Kropshofer GJ Hammerling 1997 How HLA-DM affects the peptide repertoire bound to HLA-DR molecules Hum Immunol 54 170 179 9297535 (Pubitemid 27381026)
40. SO Arndt AB Vogt GJ Hammerling H Kropshofer 1997 Selection of the MHC class II-associated peptide repertoire by HLA-DM Immunol Res 16 261 272 9379076 (Pubitemid 27455324)
41. SB Lovitch SJ Petzold ER Unanue 2003 Cutting edge: H-2DM is responsible for the large differences in presentation among peptides selected by I-Ak during antigen processing J Immunol 171 2183 2186 12928360
42. CA Lazarski FA Chaves AJ Sant 2006 The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability J Exp Med 203 1319 1328 16682499
43. AJ Sant FA Chaves FR Krafcik CA Lazarski P Menges K Richards JM Weaver 2007 Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design Expert Rev Vaccines 6 357 368 17542751
44. SJ Brett KB Cease JA Berzofsky 1988 Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing J Exp Med 168 357 373 2456373
45. H Zhu K Liu J Cerny T Imoto KD Moudgil 2005 Insertion of the dibasic motif in the flanking region of a cryptic self-determinant leads to activation of the epitope-specific T cells J Immunol 175 2252 2260 16081793
46. SA Brown J Stambas X Zhan KS Slobod C Coleclough A Zirkel S Surman SW White PC Doherty JL Hurwitz 2003 Clustering of Th cell epitopes on exposed regions of HIV envelope despite defects in antibody activity J Immunol 171 4140 4148 14530336
47. L Adorini E Appella G Doria ZA Nagy 1988 Mechanisms influencing the immunodominance of T cell determinants J Exp Med 168 2091 2104 2462005
48. JM Weaver CA Lazarski KA Richards FA Chaves SA Jenks PR Menges AJ Sant 2008 Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design J Immunol 181 3039 3048 18713974
49. CL Lazarski F Chaves S Jenks S Wu K Richards JM Weaver A Sant 2005 The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance Immunity 23 29 40 16039577 (Pubitemid 41019655)
50. P Martineau JG Guillet C Leclerc M Hofnung 1992 Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes Gene 118 151 1380939
51. R Lo-Man P Martineau M Hofnung C Leclerc 1993 Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope Eur J Immunol 23 2998 3002 8223877
52. RT Carson KM Vignali DL Woodland DA Vignali 1997 T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage Immunity 7 387 399 9324359
53. PY Arnold NL La Gruta T Miller KM Vignali PS Adams DL Woodland DA Vignali 2002 The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues J Immunol 169 739 749 12097376
54. GS Bixler Jr MZ Atassi 1984 T cell recognition of myoglobin. Localization of the sites stimulating T cell proliferative responses by synthetic overlapping peptides encompassing the entire molecule J Immunogenet 11 339 353 6085693
55. I Berkower LA Matis GK Buckenmeyer FR Gurd DL Longo JA Berzofsky 1984 Identification of distinct predominant epitopes recognized by myoglobin-specific T cells under the control of different Ir genes and characterization of representative T cell clones J Immunol 132 1370 1378 6198391
56. SL Reiner DJ Fowell NH Moskowitz K Swier DR Brown CR Brown CW Turck PA Scott N Killeen RM Locksley 1998 Control of Leishmania major by a monoclonal alpha beta T cell repertoire J Immunol 160 884 889 9551925
57. DB Stetson M Mohrs V Mallet-Designe L Teyton RM Locksley 2002 Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo Immunity 17 191 200 12196290
58. KD Moudgil J Wang VP Yeung EE Sercarz 1998 Heterogeneity of the T cell response to immunodominant determinants within hen eggwhite lysozyme of individual syngeneic hybrid F1 mice: implications for autoimmunity and infection J Immunol 161 6046 6053 9834087
59. KD Moudgil D Sekiguchi SY Kim EE Sercarz 1997 Immunodominance is independent of structural constraints: each region within hen eggwhite lysozyme is potentially available upon processing of native antigen J Immunol 159 2574 2579 9300675
60. R Shimonkevitz S Colon JW Kappler P Marrack HM Grey 1984 Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen J Immunol 133 2067 2074 6332146
61. BJ McFarland AJ Sant TP Lybrand C Beeson 1999 Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers Biochemistry 38 16663 16670 10600129
62. P Martineau C Leclerc M Hofnung 1996 Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein Mol Immunol 33 1345 1358 9171894
63. S Wouters E Decroly M Vandenbranden D Shober R Fuchs V Morel M Leruth NG Seidah PJ Courtoy JM Ruysschaert 1999 Occurrence of an HIV-1 gp160 endoproteolytic activity in low-density vesicles and evidence for a distinct density distribution from endogenously expressed furin and PC7/LPC convertases FEBS Lett 456 97 102 10452538
64. DF Steiner 1998 The proprotein convertases Curr Opin Chem Biol 2 31 39 9667917
65. JM Glandieres M Hertzog N Lazar N Brakch P Cohen B Alpert M Rholam 2002 Kinetics of precursor cleavage at the dibasic sites. Involvement of peptide dynamics FEBS Lett 516 75 79 11959107
66. M Rholam N Brakch D Germain DY Thomas C Fahy H Boussetta G Boileau P Cohen 1995 Role of amino acid sequences flanking dibasic cleavage sites in precursor proteolytic processing. The importance of the first residue C-terminal of the cleavage site Eur J Biochem 227 707 714 7867629
67. M Chretien 2005 Endoproteolysis in health and diseases-implications of proprotein convertases (PCs) J Mol Med 83 842 843 16151759
68. C Bachert C Fimmel AD Linstedt 2007 Endosomal trafficking and proprotein convertase cleavage of cis golgi protein GP73 produces marker for hepatocellular carcinoma Traffic 8 10 1415 1423 17662025
69. RM Richards DR Lowy JT Schiller PM Day 2006 Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection Proc Natl Acad Sci USA 103 1522 1527 16432208
70. G Mayer G Boileau M Bendayan 2004 Sorting of furin in polarized epithelial and endothelial cells: expression beyond the Golgi apparatus J Histochem Cytochem 52 567 579 15100235
71. G Gammon HM Geysen RJ Apple E Pickett M Palmer A Ametani EE Sercarz 1991 T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes J Exp Med 173 609 617 1705279
72. DA Weber BD Evavold PE Jensen 1996 Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM Science 274 618 620 8849454
73. FA Chaves KA Richards A Torelli J Wedekind AJ Sant 2006 Peptide-binding motifs for the I-Ad MHC class II molecule: alternate pH-dependent binding behavior Biochemistry 45 6426 6433 16700553
74. Chaves FA, Sant AJ. Measurement of peptide dissociation from MHC class II molecules. Curr Protoc Immunol. 2007;Chapter 18:Unit 18 14.
75. B McFarland JF Katz C Beeson AJ Sant 2001 Energetic asymmetry among hydrogen bonds in MHC class II:peptide complexes Proc Natl Acad Sci USA 98 9231 9236 11470892
76. A Bandyopadhyay L Arneson C Beeson AJ Sant 2008 The relative energetic contributions of dominant P1 pocket versus hydrogen bonding interactions to peptide:class II stability: implications for the mechanism of DM function Mol Immunol 45 1248 1257 17980431
77. MP Belmares R Busch ED Mellins HM McConnell 2003 Formation of two peptide/MHC II isomers is catalyzed differentially by HLA-DM Biochemistry 42 838 847 12534297
78. AB Vogt H Kropshofer G Moldenhauer GJ Hammerling 1996 Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM Proc Natl Acad Sci USA 93 9724 9729 8790398
79. H Kropshofer GJ Hammerling AB Vogt 1999 The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules Immunol Rev 172 267 278 10631952
80. VS Sloan P Cameron G Porter M Gammon M Amaya E Mellins DM Zaller 1995 Mediation by HLA-DM of dissociation of peptides from HLA-DR Nature 375 802 806 7596415
81. L Raddrizzani E Bono AB Vogt H Kropshofer F Gallazzi T Sturniolo GJ Hammerling F Sinigaglia J Hammer 1999 Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM Eur J Immunol 29 660 668 10064083
82. CL Chou S Sadegh-Nasseri 2000 HLA-DM recognizes the flexible conformation of major histocompatibility complex class II J Exp Med 192 1697 1706 11120767
83. E Stratikos DC Wiley LJ Stern 2004 Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain J Immunol 172 1109 1117 14707085
84. S Stoll J Delon TM Brotz RN Germain 2002 Dynamic imaging of T cell-dendritic cell interactions in lymph nodes [see comment] Science 296 1873 1876 12052961
85. MJ Miller AS Hejazi SH Wei MD Cahalan I Parker 2004 T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node Proc Natl Acad Sci USA 101 998 1003 14722354
86. G Shakhar RL Lindquist D Skokos D Dudziak JH Huang MC Nussenzweig M Dustin 2005 Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo Nat Immunol 6 707 714 15924144
87. T Mempel S Henrickson U von Andrian 2004 T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases Nature 427 154 159 14712275
88. S Hugues L Fetler L Bonifaz J Helft F Amblard S Amigorena 2004 Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity Nat Immunol 5 1235 1242 15516925
89. M Gunzer A Schafer S Borgmann S Grabbe K Zanker E Brocker E Kampgen P Friedl 2000 Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential Immunity 13 323 332 11021530
90. P Bousso E Robey 2003 Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes Nat Immunol 4 579 585 12730692
91. S Henrickson T Mempel I Mazo B Liu M Artyomov H Zheng A Peixoto M Flynn B Senman T Junt H Wong A Chakraborty U von Andrian 2008 T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation Nat Immunol 9 282 291 18204450
92. Q Tang JY Adams AJ Tooley M Bi BT Fife P Serra P Santamaria RM Locksley MF Krummel JA Bluestone 2006 Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice Nat Immunol 7 83 92 16311599
93. CE Tadokoro G Shakhar S Shen Y Ding AC Lino A Maraver JJ Lafaille ML Dustin 2006 Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo J Exp Med 203 505 511 16533880
94. A Scholer S Hugues A Boissonnas L Fetler S Amigorena 2008 Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory Immunity 28 258 270 18275834
95. M Mittelbrunn G Martinez Del Hoyo M Lopez-Bravo NB Martin-Cofreces A Scholer S Hugues L Fetler S Amigorena C Ardavin F Sanchez-Madrid 2009 Imaging of plasmacytoid dendritic cell interactions with T cells Blood 113 1 75 84 18818393
96. H Qi JL Cannons F Klauschen PL Schwartzberg RN Germain 2008 SAP-controlled T-B cell interactions underlie germinal centre formation Nature 455 764 769 18843362
97. CA Yarke SL Dalheimer N Zhang DM Catron MK Jenkins DL Mueller 2008 Proliferating CD4 T cells undergo immediate growth arrest upon cessation of TCR signaling in vivo J Immunol 180 156 162 18097015
98. F Gao EA Weaver Z Lu Y Li HX Liao B Ma SM Alam RM Scearce LL Sutherland JS Yu JM Decker GM Shaw DC Montefiori BT Korber BH Hahn BF Haynes 2005 Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group m consensus envelope glycoprotein J Virol 79 1154 1163 15613343
99. S Celli F Lemaitre P Bousso 2007 Real-time manipulation of T cell-dendritic cell interactions in vivo reveals the importance of prolonged contacts for CD4 T cell activation Immunity 27 625 634 17950004
100. KA Richards FA Chaves FR Krafcik DJ Topham CA Lazarski AJ Sant 2007 Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin J Virol 81 7608 7619 17507491
101. A Hamilton-Easton M Eichelberger 1995 Virus-specific antigen presentation by different subsets of cells from lung and mediastinal lymph node tissues of influenza virus-infected mice J Virol 69 6359 6366 7666537
102. CH Geurtsvankessel MA Willart LS van Rijt F Muskens M Kool C Baas K Thielemans C Bennett BE Clausen HC Hoogsteden AD Osterhaus GF Rimmelzwaan BN Lambrecht 2008 Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells J Exp Med 205 1621 1634 18591406
103. J Moyron-Quiroz J Rangel-Moreno DM Carragher TD Randall 2007 The function of local lymphoid tissues in pulmonary immune responses Adv Exp Med Biol 590 55 68 17191377
104. N Baumgarth L Brown D Jackson A Kelso 1994 Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10 J Virol 68 7575 7581 7933145
105. KL Legge TJ Braciale 2003 Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection Immunity 18 265 277 12594953
106. A Bender M Albert A Reddy M Feldman B Sauter G Kaplan W Hellman N Bhardwaj 1998 The distinctive features of influenza virus infection of dendritic cells Immunobiology 198 552 567 9561373
107. S Weiss B Bogen 1991 MHC class II-restricted presentation of intracellular antigen Cell 64 767 776 1847667
108. AJ Sant 1994 Endogenous antigen presentation by MHC class II molecules Immunol Res 13 253 267 7616053
109. GE Loss Jr CG Elias PE Fields RK Ribaudo M McKisic AJ Sant 1993 Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways J Exp Med 178 73 85 8315396
110. MS Marks 1998 Protein sorting within the MHC class II antigen-processing pathway Immunol Res 17 141 154 9479576
111. R Lechler G Aichinger L Lightstone 1996 The endogenous pathway of MHC class II antigen presentation Immunol Rev 151 51 79 8872485
112. G Kochs A Garcia-Sastre L Martinez-Sobrido 2007 Multiple anti-interferon actions of the influenza A virus NS1 protein J Virol 81 7011 7021 17442719
113. G Neumann MR Castrucci Y Kawaoka 1997 Nuclear import and export of influenza virus nucleoprotein J Virol 71 9690 9700 9371635
114. Q Ye RM Krug YJ Tao 2006 The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA Nature 444 1078 1082 17151603
115. R Bullido P Gomez-Puertas C Albo A Portela 2000 Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein J Gen Virol 81 135 142 10640551
116. R Murayama Y Harada T Shibata K Kuroda S Hayakawa K Shimizu T Tanaka 2007 Influenza A virus non-structural protein 1 (NS1) interacts with cellular multifunctional protein nucleolin during infection Biochem Biophys Res Commun 362 880 885 17767916
117. A Fernandez-Sesma 2007 The influenza virus NS1 protein: inhibitor of innate and adaptive immunity Infect Disord Drug Targets 7 336 343 18220965
118. S Boulo H Akarsu RW Ruigrok F Baudin 2007 Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes Virus Res 124 12 21 17081640
119. OG Engelhardt E Fodor 2006 Functional association between viral and cellular transcription during influenza virus infection Rev Med Virol 16 329 345 16933365
120. C Scholtissek 1991 Synthesis and function of influenza A virus glycoproteins Behring Inst Mitt 89 46 53 1930103
121. H Meier-Ewert RW Compans 1974 Time course of synthesis and assembly of influenza virus proteins J Virol 14 1083 1091 4473567
122. A Jalanko A Kallio M Salminen I Ulmanen 1989 Efficient synthesis of influenza virus hemagglutinin in mammalian cells with an extrachromosomal Epstein-Barr virus vector Gene 78 287 296 2550325
123. C Alfonso JO Han GS Williams L Karlsson 2001 The impact of H2-DM on humoral immune responses J Immunol 167 6348 6355 11714799
124. SL Swain H Hu G Huston 1999 Class II-independent generation of CD4 memory T cells from effectors Science 286 1381 1383 10558997
125. B Seddon P Tomlinson R Zamoyska 2003 Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells Nat Immunol 4 680 686 12808452
126. JF Purton JT Tan MP Rubinstein DM Kim J Sprent CD Surh 2007 Antiviral CD4+ memory T cells are IL-15 dependent J Exp Med 204 951 961 17420265
127. G Kassiotis S Garcia E Simpson B Stockinger 2002 Impairment of immunological memory in the absence of MHC despite survival of memory T cells Nat Immunol 3 244 250 11836529
128. DM Catron LK Rusch J Hataye AA Itano MK Jenkins 2006 CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells J Exp Med 203 1045 1054 16567390
129. G Kassiotis D Gray Z Kiafard J Zwirner B Stockinger 2006 Functional specialization of memory Th cells revealed by expression of integrin CD49b J Immunol 177 968 975 16818752
130. E Godebu D Summers-Torres MM Lin BJ Baaten LM Bradley 2008 Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cells J Immunol 181 1798 1805 18641317
131. F Sallusto D Lenig R Forster M Lipp A Lanzavecchia 1999 Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 708 712 10537110
132. N Fazilleau MD Eisenbraun L Malherbe JN Ebright RR Pogue-Caley LJ McHeyzer-Williams MG McHeyzer-Williams 2007 Lymphoid reservoirs of antigen-specific memory T helper cells Nat Immunol 8 753 761 17529982 (Pubitemid 46965351)
133. B Peters A Sette 2007 Integrating epitope data into the emerging web of biomedical knowledge resources Nat Rev Immunol 7 485 490 17479127
134. A Sette B Peters 2007 Immune epitope mapping in the post-genomic era: lessons for vaccine development Curr Opin Immunol 19 106 110 17113275
135. MN Davies DR Flower 2007 Harnessing bioinformatics to discover new vaccines Drug Discov Today 12 389 395 17467575
136. S Sundaresh A Randall B Unal JM Petersen JT Belisle MG Hartley M Duffield RW Titball DH Davies PL Felgner P Baldi 2007 From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis Bioinformatics 23 i508 i518 17646338
137. A Sette M Newman B Livingston D McKinney J Sidney G Ishioka S Tangri J Alexander J Fikes R Chesnut 2002 Optimizing vaccine design for cellular processing, MHC binding and TCR recognition Tissue Antigens 59 443 451 12445314
138. A Sette E Keogh G Ishioka J Sidney S Tangri B Livingston D McKinney M Newman R Chesnut J Fikes 2002 Epitope identification and vaccine design for cancer immunotherapy Curr Opin Investig Drugs 3 132 139 12054064
139. M Terajima J Cruz G Raines ED Kilpatrick JS Kennedy AL Rothman FA Ennis 2003 Quantitation of CD8+ T cell responses to newly identified HLA-A0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses J Exp Med 197 927 932 12668642
140. A Wahl J Weidanz W Hildebrand 2006 Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells Expert Rev Proteomics 3 641 652 17181478
141. A Sette J Fikes 2003 Epitope-based vaccines: an update on epitope identification, vaccine design and delivery Curr Opin Immunol 15 461 470 12900280
142. H Qin C Zhou D Wang W Ma X Liang C Lin Y Zhang S Zhang 2005 Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens Immunol Lett 99 85 93 15894116
143. L Chen T Gao N Yang J Huang Y Chen T Gao Q Li D Ren 2007 Immunization with a synthetic multiepitope antigen induces humoral and cellular immune responses to hepatitis C virus in mice Viral Immunol 20 170 179 17425431
144. A Fournillier P Dupeyrot P Martin P Parroche A Pajot L Chatel A Fatmi E Gerossier C Bain YC Lone C Trepo G Inchauspe 2006 Primary and memory T cell responses induced by hepatitis C virus multiepitope long peptides Vaccine 24 3153 3164 16481078
145. JM Vuola S Keating DP Webster T Berthoud S Dunachie SC Gilbert AV Hill 2005 Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers J Immunol 174 449 455 15611270
146. T Kanto N Hayashi 2006 Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity Intern Med 45 183 191 16543687
147. DH Fremont WA Hendrickson P Marrack J Kappler 1996 Structures of an MHC class II molecule with covalently bound single peptides Science 272 1001 1004 8638119
148. MN Davies DR Flower 2007 Static energy analysis of MHC class I and class II peptide-binding affinity Methods Mol Biol 409 309 320 18450011
149. Y Zhu AY Rudensky AL Corper L Teyton IA Wilson 2003 Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif J Mol Biol 326 1157 1174 12589760
150. N Kumar D Mohanty 2007 MODPROPEP: a program for knowledge-based modeling of protein-peptide complexes Nucleic Acids Res 35 W549 W555 17478500
151. W Zhang J Liu YQ Niu L Wang X Hu 2008 A Bayesian regression approach to the prediction of MHC-II binding affinity Comput Methods Programs Biomed 92 1 7 18562039
152. JM Calvo-Calle I Strug MD Nastke SP Baker LJ Stern 2007 Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection PLoS Pathog 3 1511 1529 17937498
153. A Sette J Sidney MF del Guercio S Southwood J Ruppert C Dahlberg HM Grey RT Kubo 1994 Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays Mol Immunol 31 813 822 8047072
154. M Nielsen C Lundegaard T Blicher B Peters A Sette S Justesen S Buus O Lund 2008 Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan PLoS Comput Biol 4 e1000107 18604266